DCF — HUNTERDON MEDICAL CENTER
Enterprise Value: $-549.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-549.5M
Enterprise Value
$-174.7M
PV of Cash Flows
$-374.8M
PV of Terminal Value
$-603.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $369.1M | $-33.8M | -9.0% | $-49.4M | $-44.9M |
| Year 2 | $380.2M | $-31.0M | -8.0% | $-47.1M | $-38.9M |
| Year 3 | $391.6M | $-28.0M | -7.0% | $-44.6M | $-33.5M |
| Year 4 | $403.3M | $-26.8M | -7.0% | $-43.9M | $-30.0M |
| Year 5 | $415.4M | $-26.6M | -6.0% | $-44.2M | $-27.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-549.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$358.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09649762797302645
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5